A Narrative Review of Recent Developments in Aspirin Therapy After Desensitization in NSAIDs-Exacerbated Respiratory Disease
Journal of Inflammation Research · 2026-08 · Volume 19 · 1-23
DOI: 10.2147/jir.s620047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-08. Verfasst von Preena Ketan Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Imperial College Healthcare NHS Trust, London, UK. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Imperial College Healthcare NHS Trust, London, UK.
- Ear Institute, University College London (UCL), London, UK.
- Department of ENT, Royal National ENT & Eastman Dental Hospitals, London, UK.
- Division of Immunity and Infection, University College London (UCL), London, UK.
ORCID-Profile: Glenis K Scadding, Alfonso Luca Pendolino
Zitieren
APA
Patel, P. K., Sharma Khatiwada, A., Andrews, P. J., Scadding, G. K., & Pendolino, A. L. (2026). A Narrative Review of Recent Developments in Aspirin Therapy After Desensitization in NSAIDs-Exacerbated Respiratory Disease. Journal of Inflammation Research, Volume 19, 1-23. https://doi.org/10.2147/jir.s620047
Vancouver
Patel PK, Sharma Khatiwada A, Andrews PJ, Scadding GK, Pendolino AL. A Narrative Review of Recent Developments in Aspirin Therapy After Desensitization in NSAIDs-Exacerbated Respiratory Disease. Journal of Inflammation Research. 2026;Volume 19:1-23. doi:10.2147/jir.s620047
BibTeX
@article{Patel2026,
author = {Patel, Preena Ketan and Sharma Khatiwada, Aagat and Andrews, Peter J and Scadding, Glenis K and Pendolino, Alfonso Luca},
title = {A Narrative Review of Recent Developments in Aspirin Therapy After Desensitization in NSAIDs-Exacerbated Respiratory Disease},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--23},
doi = {10.2147/jir.s620047}
}
EUVIMED